Dante Genomics

Dante Genomics is a leading global genomics and precision medicine company working to deliver better healthcare and save lives with a more human approach to health. We work with customers across 97 countries and we create customized genomic analysis processes that have an impact on people’s lives. Our mission is to accelerate science for the people. We leverage genome sequencing technology and interpretation so that everyone can make informed decisions about their health and their future. We use the proprietary genomic platform, based on artificial intelligence and machine learning, capable of integrating and optimizing all resources and information, creating important synergies for our stakeholders. We also collaborate with international associations and advocacy groups to find solutions to improve the quality of life of patients. In 2019 the two founders won the EY award as "best entrepreneurs of the year" and the company took sixth place in the list of 2023 growth leaders compiled by Statista and Il Sole 24 Ore. More information is available at www.dantegenomics.com